 SALT LAKE CITY , March 22, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will present at the 3rd Annual MarketsandMarkets Infectious Disease Diagnostics and Molecular Diagnostics Conference, held March 23-24, 2022, in London, England. Co-Diagnostics CEO Dwight Egan will be presenting on the Companys YourTestTM PCR at-homepoint-of-care testing device to the international audience at 14:00 GMT on March 23rd. 